{"entity":{"type":"insider","cik":"0001884342","url":"/insider/0001884342","json_url":"/insider/0001884342.json","name":"O'Malley Brendan M.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":15,"first":"2021-10-08","last":"2026-07-09","span_basis":"filed_date"},"name_variants":[{"name":"O'Malley Brendan M.","source":"filing","n_filings":15,"first_seen":"2021-10-08","last_seen":"2026-07-09"}],"transactions":[{"id":6076066,"accession":"0001493152-26-032742","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-032742","line_url":"/filing/0001493152-26-032742#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001884342","owner_name":"O'Malley Brendan M.","owner_display_name":"O'Malley Brendan M.","owner_url":"/insider/0001884342","role":"Officer (SVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12050.0,"shares_display":"12,050","price_per_share":6.9637,"price_display":"6.96","price_state":"stated","total_value":83912.585,"total_display":"83,912.58","total_whole":"83,913","shares_owned_after":427953.0,"shares_owned_after_display":"427,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-09","filed_date":"2026-07-09","scope":"insider"},{"id":5777616,"accession":"0001493152-26-028019","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-26-028019","line_url":"/filing/0001493152-26-028019#line-2","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001884342","owner_name":"O'Malley Brendan M.","owner_display_name":"O'Malley Brendan M.","owner_url":"/insider/0001884342","role":"Officer (SVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6305.0,"shares_display":"6,305","price_per_share":5.3042,"price_display":"5.30","price_state":"stated","total_value":33442.981,"total_display":"33,442.98","total_whole":"33,443","shares_owned_after":440003.0,"shares_owned_after_display":"440,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-09","filed_date":"2026-06-09","scope":"insider"},{"id":5777615,"accession":"0001493152-26-028019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-028019","line_url":"/filing/0001493152-26-028019#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001884342","owner_name":"O'Malley Brendan M.","owner_display_name":"O'Malley Brendan M.","owner_url":"/insider/0001884342","role":"Officer (SVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4826.0,"shares_display":"4,826","price_per_share":5.4295,"price_display":"5.43","price_state":"stated","total_value":26202.767,"total_display":"26,202.77","total_whole":"26,203","shares_owned_after":446308.0,"shares_owned_after_display":"446,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-08","filed_date":"2026-06-09","scope":"insider"},{"id":5862396,"accession":"0001493152-26-003282","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-003282","line_url":"/filing/0001493152-26-003282#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001884342","owner_name":"O'Malley Brendan M.","owner_display_name":"O'Malley Brendan M.","owner_url":"/insider/0001884342","role":"Officer (SVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13578.0,"shares_display":"13,578","price_per_share":5.3309,"price_display":"5.33","price_state":"stated","total_value":72382.9602,"total_display":"72,382.96","total_whole":"72,383","shares_owned_after":451134.0,"shares_owned_after_display":"451,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-22","scope":"insider"},{"id":4152083,"accession":"0001493152-25-016544","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-016544","line_url":"/filing/0001493152-25-016544#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001884342","owner_name":"O'Malley Brendan M.","owner_display_name":"O'Malley Brendan M.","owner_url":"/insider/0001884342","role":"Officer (SVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9366.0,"shares_display":"9,366","price_per_share":5.3935,"price_display":"5.39","price_state":"stated","total_value":50515.521,"total_display":"50,515.52","total_whole":"50,516","shares_owned_after":350763.0,"shares_owned_after_display":"350,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-29","filed_date":"2025-10-01","scope":"insider"},{"id":5049091,"accession":"0001493152-25-014527","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-014527","line_url":"/filing/0001493152-25-014527#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001884342","owner_name":"O'Malley Brendan M.","owner_display_name":"O'Malley Brendan M.","owner_url":"/insider/0001884342","role":"Officer (SVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":688.0,"shares_display":"688","price_per_share":5.43,"price_display":"5.43","price_state":"stated","total_value":3735.84,"total_display":"3,735.84","total_whole":"3,736","shares_owned_after":360129.0,"shares_owned_after_display":"360,129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-22","filed_date":"2025-09-22","scope":"insider"},{"id":4811540,"accession":"0001641172-25-018601","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-018601","line_url":"/filing/0001641172-25-018601#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001884342","owner_name":"O'Malley Brendan M.","owner_display_name":"O'Malley Brendan M.","owner_url":"/insider/0001884342","role":"Officer (SVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17428.0,"shares_display":"17,428","price_per_share":5.8557,"price_display":"5.86","price_state":"stated","total_value":102053.1396,"total_display":"102,053.14","total_whole":"102,053","shares_owned_after":360817.0,"shares_owned_after_display":"360,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-09","filed_date":"2025-07-10","scope":"insider"},{"id":4437187,"accession":"0001641172-25-014167","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-014167","line_url":"/filing/0001641172-25-014167#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001884342","owner_name":"O'Malley Brendan M.","owner_display_name":"O'Malley Brendan M.","owner_url":"/insider/0001884342","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10470.0,"shares_display":"10,470","price_per_share":6.76,"price_display":"6.76","price_state":"stated","total_value":70777.2,"total_display":"70,777.20","total_whole":"70,777","shares_owned_after":378245.0,"shares_owned_after_display":"378,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-06","filed_date":"2025-06-06","scope":"insider"},{"id":2911824,"accession":"0001493152-24-016064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-016064","line_url":"/filing/0001493152-24-016064#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001884342","owner_name":"O'Malley Brendan M.","owner_display_name":"O'Malley Brendan M.","owner_url":"/insider/0001884342","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8600.0,"shares_display":"8,600","price_per_share":3.24,"price_display":"3.24","price_state":"stated","total_value":27864.0,"total_display":"27,864.00","total_whole":"27,864","shares_owned_after":188718.0,"shares_owned_after_display":"188,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-25","filed_date":"2024-04-26","scope":"insider"},{"id":8712773,"accession":"0001493152-23-033000","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-033000","line_url":"/filing/0001493152-23-033000#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001884342","owner_name":"O'Malley Brendan M.","owner_display_name":"O'Malley Brendan M.","owner_url":"/insider/0001884342","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.8,"price_display":"3.80","price_state":"stated","total_value":11400.0,"total_display":"11,400.00","total_whole":"11,400","shares_owned_after":187421.0,"shares_owned_after_display":"187,421","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-18","filed_date":"2023-09-19","scope":"insider"},{"id":6626052,"accession":"0001493152-22-035169","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-035169","line_url":"/filing/0001493152-22-035169#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001884342","owner_name":"O'Malley Brendan M.","owner_display_name":"O'Malley Brendan M.","owner_url":"/insider/0001884342","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5869.0,"shares_display":"5,869","price_per_share":3.13,"price_display":"3.13","price_state":"stated","total_value":18369.97,"total_display":"18,369.97","total_whole":"18,370","shares_owned_after":93830.0,"shares_owned_after_display":"93,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-09","filed_date":"2022-12-12","scope":"insider"},{"id":6483844,"accession":"0001493152-22-033016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-033016","line_url":"/filing/0001493152-22-033016#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001884342","owner_name":"O'Malley Brendan M.","owner_display_name":"O'Malley Brendan M.","owner_url":"/insider/0001884342","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":3.99,"price_display":"3.99","price_state":"stated","total_value":29925.0,"total_display":"29,925.00","total_whole":"29,925","shares_owned_after":87961.0,"shares_owned_after_display":"87,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-18","filed_date":"2022-11-21","scope":"insider"},{"id":4696466,"accession":"0001493152-21-030876","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-030876","line_url":"/filing/0001493152-21-030876#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001884342","owner_name":"O'Malley Brendan M.","owner_display_name":"O'Malley Brendan M.","owner_url":"/insider/0001884342","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8880.0,"shares_display":"8,880","price_per_share":0.567,"price_display":"0.57","price_state":"stated","total_value":5034.96,"total_display":"5,034.96","total_whole":"5,035","shares_owned_after":204750.0,"shares_owned_after_display":"204,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-08","scope":"insider"},{"id":5223788,"accession":"0001493152-21-027433","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-027433","line_url":"/filing/0001493152-21-027433#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001884342","owner_name":"O'Malley Brendan M.","owner_display_name":"O'Malley Brendan M.","owner_url":"/insider/0001884342","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8880.0,"shares_display":"8,880","price_per_share":0.889,"price_display":"0.89","price_state":"stated","total_value":7894.32,"total_display":"7,894.32","total_whole":"7,894","shares_owned_after":213630.0,"shares_owned_after_display":"213,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-05","filed_date":"2021-11-05","scope":"insider"},{"id":5434967,"accession":"0001493152-21-025348","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-025348","line_url":"/filing/0001493152-21-025348#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001884342","owner_name":"O'Malley Brendan M.","owner_display_name":"O'Malley Brendan M.","owner_url":"/insider/0001884342","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25734.0,"shares_display":"25,734","price_per_share":0.9043,"price_display":"0.90","price_state":"stated","total_value":23271.2562,"total_display":"23,271.26","total_whole":"23,271","shares_owned_after":222510.0,"shares_owned_after_display":"222,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-11","filed_date":"2021-10-13","scope":"insider"},{"id":4143951,"accession":"0001493152-21-025084","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-21-025084","line_url":"/filing/0001493152-21-025084#line-2","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001884342","owner_name":"O'Malley Brendan M.","owner_display_name":"O'Malley Brendan M.","owner_url":"/insider/0001884342","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22763.0,"shares_display":"22,763","price_per_share":1.0506,"price_display":"1.05","price_state":"stated","total_value":23914.8078,"total_display":"23,914.81","total_whole":"23,915","shares_owned_after":248244.0,"shares_owned_after_display":"248,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-08","filed_date":"2021-10-08","scope":"insider"},{"id":4143943,"accession":"0001493152-21-025084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-025084","line_url":"/filing/0001493152-21-025084#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001884342","owner_name":"O'Malley Brendan M.","owner_display_name":"O'Malley Brendan M.","owner_url":"/insider/0001884342","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2447.0,"shares_display":"2,447","price_per_share":1.05,"price_display":"1.05","price_state":"stated","total_value":2569.35,"total_display":"2,569.35","total_whole":"2,569","shares_owned_after":271007.0,"shares_owned_after_display":"271,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-05","filed_date":"2021-10-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000318306","name":"ABEONA THERAPEUTICS INC.","url":"/issuer/0000318306","role":"Officer (SVP, Chief Legal Officer)","n_filings":15,"first_seen":"2021-10-08","last_seen":"2026-07-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001884342","retrieved_at":"2026-08-24T19:49:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}